CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOACaptura de pantalla 2022 09 14 a las 10.27.10    

Genome maintenance and variability: enzymology of DNA replication and repair

Research summary:

Work done in the last decade has revealed that DNA replication is a major source of genomic instability, due to rearrangements that occur at sites of stalled replication forks. These problems are overall defined as replication stress” (RS). Along the last five years we have contributed to demostrate that the majority of DNA lesions or blocking structures occurring in the template DNA may be tolerated” during RS, mainly through the generation of PrimPol-mediated new replicative starting points (namely primers) in the leading strand, immediately beyond the lesion. Importantly, our discovery of PrimPol leads to reconsider the molecular scenario in which the DNA lesion is subsequently repaired, implying the existence of remaining small DNA gaps containing the lesion, generated after PrimPol-mediated restart, that need to be filled, processed, and finally sealed. We are currently interested in the identification and characterization of potential PrimPol interactors, and in the basic mechanism of the subsequent damage tolerance and repair transactions needed behind, after PrimPol-mediated fork restart.

It is worth mentioning that PrimPol inactivation or removal during the replication of nuclear DNA entails a significant reduction of replication fork speed, indicating its relevant role in physiological conditions. Thus, whereas PrimPol-deficient mice and siRNA-depleted human cells were viable, they show large symptoms of genomic instability, very likely related to the augmented DNA RS in these cells.

On the other hand, in the presence of RS induced by replication inhibitors or topoisomerase poisons, such as camptothecin and etoposide, PrimPol deficiency generates a strong and persistent increase in RS signaling, leading to augmented genetic instability, a hallmark of cancer cells. Altogether, our data strongly suggest that PrimPol is a novel and relevant target in cancer. Its deficiency, either due to specific inactivating mutations or to the use of specific inhibitors, in combination with other well known genotoxic agents, would lead to high replicative stress burden causing tumor cells death by replication catastrophe. Thus, another objective of our research is the analysis of human PrimPol regulation, and the characterization of human PrimPol cancer variants with altered specific activity and primase deficiency, that could have a pronostic value in cancer.

From a biotechnological perspective, we have developed a high-trhougput secreening to obtain PrimPol variants with altered specificity that could be relevant for a novel PrimPol-based DNA amplification method named TruePrime™, currently commercialized by Expedeon AG (currently 4BaseBio AG), for the diagnosis of cancer in liquid biopsies.

Image

Figure 1. Schematic represention of PrimPol acting at a stalled replication fork. After PrimPol recruitment via RPA and subsequent synthesis of a DNA primer, fork progression is re-stablished, and a lesion-containing gap is left behind, which requires the direct action of TLS polymerases, or template-switch (damage avoidance) events to copy the newly synthesized/undamaged daughter strand. RNA primers in the lagging strand (green) or an eventual DNA primer made by PrimPol in the leading strand (cyan) are numbered according to their proposed order of synthesis.

Image

Figure 2. Mechanism of DNA priming by human PrimPol. A) Structural comparison of human Pri1/PriS/p49 and human PrimPol. B) Sequential steps during primer synthesis by human PrimPol.

Image


* For external calls please dial 34 91196 followed by the extension number
Last nameNameLaboratoryExt.*e-mailProfessional category
Blanco DávilaLuis4034685lblanco(at)cbm.csic.esE. Profesores de Investigación de Organismos Públicos de Investigación
Guerra GonzálezSusana4034686sguerra(at)cbm.csic.esTco.Sup.Activ.Técn.y Profes. GP3
Jiménez JulianaMarcos4034686marcos.j(at)cbm.csic.esTitulado Sup. Actividades Tecn. y Prof.GP1
Jiménez MejíasAlejandra4034686Estudiante TFM
Martínez JiménezMaría Isabel4034686maria_m(at)cbm.csic.esDoctor FC3
Olmos GuevaraRegina4034686Estudiante

Relevant publications:

  • Blanco L, Calvo PA, Diaz-Talavera A, Carvalho G, Calero N, Martínez-Carrón A, Velázquez-Ruiz C, Villadangos S, Guerra S, Martínez-Jiménez MI (2019) Mechanismn of DNA primer synthesis by human PrimPol. Enzymes 45, 289-310. Review.
  • Calvo PA, Sastre-Moreno G, Perpiñá C, Guerra S, Martínez-Jiménez MI, Blanco L (2019) The invariant glutamate of human PrimPol DxE motif is critical for its Mn2+-dependent distinctive activities. DNA Repair (Amst) 77, 65-75.
  • Díaz-Talavera A, Calvo PA, González-Acosta D, Díaz M, Sastre-Moreno G, Blanco-Franco L, Guerra S, Martínez-Jiménez MI, Méndez J, Blanco L (2019) A cancer-associated point mutation disables the steric gate of human PrimPol. Rep. Feb 4;9(1):1121.
  • Martínez-Jiménez MI, Calvo PA, García-Gómez S, Guerra-González S, Blanco L (2018) The Zn-finger of human PrimPol is required to stabilize the initiating nucleotide during DNA priming. Nucleic Acids Res. 46, 4138-4151.
  • Torregrosa-Muñumer R, Forslund JME, Goffart S, Pfeiffer A, Stojkovič G, Carvalho G, Al-Furoukh N, Blanco L, Wanrooij S, Pohjoismäki JLO. (2017) PrimPol is required for replication reinitiation after mtDNA damage. Proc Natl Acad Sci U S A. 114, 11398-11403.
  • Agudo R, Calvo PA, Martínez-Jiménez MI, Blanco L (2017) Engineering human PrimPol into an efficient RNA-dependent-DNA primase/polymerase. Nucleic Acids Res. 45, 9046-9058.
  • Martínez-Jiménez MI, Lahera A, Blanco L (2017) Human PrimPol activity is enhanced by RPA. Sci Reports. 7(1):783. doi: 10.1038/s41598-017-00958-3. PMID: 28396594.
  • Picher AJ, Wafzig O, Krüger C, García-Gómez S, Martínez-Jiménez MI, Díaz-Talavera A, Blanco L* and Armin Schneider S* (2016) TruePrime, a novel method for whole genome amplification from single cells based on TthPrimPol. *co-corresponding authors. Nature Commun. 7:13296 | doi: 10.1038/ncomms13296.
  • Mouron S, Rodriguez-Acebes S, Martinez-Jimenez MI, Garcia-Gomez S, Chocrón ES, Blanco L*, Mendez J* (2013). Repriming of DNA synthesis at stalled replication forks by human PrimPol.  *co-corresponding authors. Nature Structural & Molecular Biology 20, 1383-1389.
  • Garcia-Gomez S, Reyes A, Martinez-Jimenez MI, Chocrón ES, Mouron S, Terrados G, Powell C, Salido, E, Mendez J, Holt IJ, Blanco L (2013). PrimPol, an Archaic Primase/Polymerase Operating in Human Cells. Molecular Cell 52, 541-53.

Doctoral theses:

  • Sara García Gómez (2013). “PrimPol, una nueva primasa/polimerasa en células humanas”. Universidad Autónoma de Madrid. Supervisors: Luis Blanco Dávila & María I. Martínez Jiménez.
  • Ana Gómez Bedoya (2013). “Análisis estructura-función de la DNA polimerasa lambda humana y su implicación en la reparación del DNA mediante NHEJ”. Universidad Autónoma de Madrid. Supervisor: Luis Blanco Dávila.
  • Ana Aza Montoya (2014). “In vivo role of DNA polymerases lambda and mu in Genome Stability”. Universidad Autónoma de Madrid. Supervisors: Luis Blanco Dávila & Gloria Terrados Aguado.
  • Guillermo Sastre Moreno (2016). “Polymerases specialized in damage tolerance and DNA double-strand break repair”. Universidad Autónoma de Madrid. Supervisors: Luis Blanco Dávila & José F. Ruiz Pérez.
  • Patricia A. Calvo Fernández (2019). “Structure-function analysis of human PrimPol”. Universidad Autónoma de Madrid. Supervisors: Luis Blanco Dávila & María I. Martínez Jiménez.

Patents:

  • A. Picher y L. Blanco. Title: Methods for amplification and sequencing using thermostable TthPrimPol. Priority number: EP13159629. Country of priority: Europe Priority date: 15 March 2013. Owner: Expedeon AG.

Other activities:

  • Coordinator of the module (BM6): "Estabilidad de la Información Genética: Replicación, Reparación y Mutagénesis", Master of Molecular and Celular Biology, Universidad Autónoma de Madrid (UAM).
  • XX Carmen & Severo Ochoa  Award in Molecular Biology (2014).

NOTE! This site uses cookies and similar technologies.

If you not change browser settings, you agree to it. Learn more

I understand

COOKIES POLICY

What are cookies?

A cookie is a file that is downloaded to your computer when you access certain web pages. Cookies allow a web page, among other things, to store and retrieve information about the browsing habits of a user or their equipment and, depending on the information they contain and the way they use their equipment, they can be used to recognize the user.

Types of cookies

Classification of cookies is made according to a series of categories. However, it is necessary to take into account that the same cookie can be included in more than one category.

  1. Cookies according to the entity that manages them

    Depending on the entity that manages the computer or domain from which the cookies are sent and treat the data obtained, we can distinguish:

    • Own cookies: those that are sent to the user's terminal equipment from a computer or domain managed by the editor itself and from which the service requested by the user is provided.
    • Third party cookies: those that are sent to the user's terminal equipment from a computer or domain that is not managed by the publisher, but by another entity that processes the data obtained through the cookies. When cookies are installed from a computer or domain managed by the publisher itself, but the information collected through them is managed by a third party, they cannot be considered as own cookies.

  2. Cookies according to the period of time they remain activated

    Depending on the length of time that they remain activated in the terminal equipment, we can distinguish:

    • Session cookies: type of cookies designed to collect and store data while the user accesses a web page. They are usually used to store information that only is kept to provide the service requested by the user on a single occasion (e.g. a list of products purchased).
    • Persistent cookies: type of cookies in which the data is still stored in the terminal and can be accessed and processed during a period defined by the person responsible for the cookie, which can range from a few minutes to several years.

  3. Cookies according to their purpose

    Depending on the purpose for which the data obtained through cookies are processed, we can distinguish between:

    • Technical cookies: those that allow the user to navigate through a web page, platform or application and the use of different options or services that exist in it, such as controlling traffic and data communication, identifying the session, access to restricted access parts, remember the elements that make up an order, perform the purchase process of an order, make a registration or participation in an event, use security elements during navigation, store content for the broadcast videos or sound or share content through social networks.
    • Personalization cookies: those that allow the user to access the service with some predefined general characteristics based on a series of criteria in the user's terminal, such as the language, the type of browser through which the user accesses the service, the regional configuration from where you access the service, etc.
    • Analytical cookies: those that allow the person responsible for them to monitor and analyse the behaviour of the users of the websites to which they are linked. The information collected through this type of cookies is used in the measurement of the activity of the websites, applications or platforms, and for the elaboration of navigation profiles of the users of said sites, applications and platforms, in order to introduce improvements in the analysis of the data of use made by the users of the service.

Cookies used on our website

The CBMSO website uses Google Analytics. Google Analytics is a simple and easy to use tool that helps website owners to measure how users interact with the content of the site. You can consult more information about the cookies used by Google Analitycs in this link.

Acceptance of the Cookies Policy

The CBMSO assumes that you accept the use of cookies if you continue browsing, considering that it is a conscious and positive action from which the user's consent is inferred. In this regard, you are previously informed that such behaviour will be interpreted that you accept the installation and use of cookies.

Knowing this information, it is possible to carry out the following actions:

  • Accept cookies: if the user presses the acceptance button, this warning will not be displayed again when accessing any page of the portal.
  • Review the cookies policy: the user can access to this page in which the use of cookies is detailed, as well as links to modify the browser settings.

How to modify the configuration of cookies

Using your browser you can restrict, block or delete cookies from any web page. In each browser the process is different, here we show you links on this particular of the most used browsers:

fondosocialeuropeo-300px.png
Ministerio-de-Ciencia-e-Innovacin-600px.png
Comunidad-de-Madrid-600Bpx.png
agenda20-30-600px.png
fundacion-areces600px0710.png
LOGO_ERC.jpg
hrexcellence.jpg
worldwidecancerresearch-600px0710.png
aecc-600tpx.png
bbva-fund-400.png
Niemann-Pick-400px.png
wilderfund-400px.png
AliciaKoplowitz-400px.png
la-caixa-fund-600px.png
inocente-inocente-600px.png
cure-alzheimers-fund-600px.png
citrin-foundation.png
tatiana-fund02-600bpx1.png
campus-excelencia-600x400px.png
fundacion-uno-entre-cien-mil-v02.png